Loading...

Assertio Holdings, Inc.

ASRT•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$18.04
$0.02(0.11%)
U.S. Market opens in NaNh NaNm

Assertio Holdings, Inc. (ASRT) Stock Overview

Explore Assertio Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap116.3M
P/E Ratio-3.92
EPS (TTM)$-4.74
ROE-0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$11.34
3 Months$10.89
1 Year Target$3.50

ASRT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Assertio Holdings, Inc. (ASRT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.92 and a market capitalization of 116.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.11%
5-Day Change
N/A
1-Month Change
9.27%
3-Month Change
56.73%
6-Month Change
46.67%
Year-to-Date (YTD) Change
98.90%
1-Year Change
90.90%
3-Year Change
-81.21%
5-Year Change
-47.25%
All-Time (Max) Change
-91.98%

Contact Information

https://www.assertiotx.com
224 419 7106
100 South Saunders Road, Lake Forest, IL, 60045

Company Facts

58 Employees
IPO DateDec 3, 1997
CountryUS
Actively Trading

Frequently Asked Questions